#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Tourette's disorder Cystic fibrosis lung Pulmonary alveolar haemorrhage Transitional cell cancer of the renal pelvis and ureter Renal cell carcinoma Immunoglobulin G4 related disease Non-renal cell carcinoma of kidney Insulinoma Chondrodystrophy Colitis ulcerative Diffuse large B-cell lymphoma refractory Cholangiocarcinoma Lupus nephritis Vulval cancer Postprandial hypoglycaemia More trials…

    Learn about Rare Diseases

    Marginal zone lymphoma refractory – Life with Disease Factor IX deficiency – Trials in Disease Brain stem glioma – Basic Information Alagille syndrome – Life with Disease Leiomyosarcoma Lysosomal storage disorder – Life with Disease Congenital generalised lipodystrophy – Basic Information Wiskott-Aldrich syndrome – Treatment Sarcoma – Diagnostics Hereditary neuropathic amyloidosis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    WEF-001 Daunorubicin Cx-039776 CC-97540 Iptacopan SULBACTAM SODIUM Ttf-Ngr Ptc518 Lanifibranor Livmoniplimab Venlafaxine Hydrochloride Alpha1H Sotagliflozin Nitrofurantoin Nicotinamide Bp For-6219 Azd5004 Istradefylline Metformin RP2 More therapies…

    Learn about Your Condition

    Poor quality sleep Renal cancer metastatic Thrombolysis Barrett's oesophagus Colon cancer stage IV Pancreatic neoplasm Hodgkin's disease recurrent Macular degeneration Thymoma Organ donor Spermatocele Oedema Partial lipodystrophy Hepatic cirrhosis Kawasaki's disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Adrenogenital syndrome

  • A Study of Atumelnant for Children with Congenital Adrenal Hyperplasia

    Recruiting

    4 1
    Investigated Diseases:
    • Adrenogenital syndrome
    Investigated Drugs:
    • ATUMELNANT
    Belgium France Germany Italy The Netherlands Poland

  • Study of crinecerfont oral solution in children under 2 years old with congenital adrenal hyperplasia to evaluate safety and how the drug works in the body

    Recruiting

    2 1 1
    Investigated Drugs:
    • Crinecerfont
    Germany

  • Study on the Safety and Effectiveness of CRN04894 for Patients with Congenital Adrenal Hyperplasia

    Recruiting

    2 1 1
    Investigated Drugs:
    • ATUMELNANT
    Germany Italy

  • Study on the Effectiveness of Dexamethasone in Preventing Prenatal Virilization in Female Patients with Congenital Adrenal Hyperplasia

    Recruiting

    2 1 1
    Investigated Diseases:
    • Adrenogenital syndrome
    Investigated Drugs:
    • Dexamethasone
    Germany

  • A Study Testing Atumelnant Compared to Placebo in Adults with Classic Congenital Adrenal Hyperplasia to Reduce Steroid Dose While Controlling Hormones

    Recruiting

    3 1
    Investigated Drugs:
    • ATUMELNANT
    Austria France Germany Italy The Netherlands Poland +1

  • Study of Crinecerfont in Adults with Classic Congenital Adrenal Hyperplasia to Reduce Androgen Levels

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Crinecerfont
    Austria Bulgaria Czechia Germany Italy Portugal +3
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!